Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Interrogating a Novel Gene Editing Strategy for Predominant Tay-Sachs Disease Mutation

EF 2021-22

Résumé
Background: Tay-Sachs Disease (TSD) is characterised by toxic build-up of a fatty substance, GM2, within neural tissue. The predominant mutation causing TSD is a small duplicated sequence of DNA. This genetic error arrests production of HexA, an enzyme required to metabolise GM2 and prevent accumulation. Absent HexA, progressive neurodegenerative symptoms of TSD emerge in infancy, typically leading to death by age 4. Though rare, this fatal disorder has no available treatment. Current Status: Recent advances in CRISPR gene editing technology have excited prospects of genetically treating TSD by directly editing out the duplication. A CRISPR-based technique called Prime Editing can repair various kinds of mutations, including the TSD duplication in a cell model, but its molecular components are too large for effective delivery to live animal models.Research Aim:Forgoing the versatility of Prime Editing, an alternative strategy tailored for editing small duplication mutations can circumvent bulky editing machinery by exploiting an internal cell pathway called MMEJ to effectuate repair. A classic CRISPR system (readily deliverable components) would be programmed to cut within the duplicated sequence at a position that induces the MMEJ repair process. Mechanistically, MMEJ is expected to rejoin the DNA break while collaterally, but precisely, removing one copy of the duplication. Our capstone deliverable is testing this minimalist CRISPR-based repair strategy on the TSD duplication in a mouse model, with precision of the DNA-level editing examined alongside efficacy of TSD symptom amelioration for relevant pre-clinical data. If successful, this strategy would be highly applicable to editing over 140 comparable duplication mutations causing various diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466725
Name
Hung Joshua E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Interrogating a Novel Gene Editing Strategy for Predominant Tay-Sachs Disease Mutation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Crispr/Cas; Gene Editing; Microduplication Mutation; Mmej Dna Repair; Mouse Models; Tay-Sachs Disease
Abstract
Background: Tay-Sachs Disease (TSD) is characterised by toxic build-up of a fatty substance, GM2, within neural tissue. The predominant mutation causing TSD is a small duplicated sequence of DNA. This genetic error arrests production of HexA, an enzyme required to metabolise GM2 and prevent accumulation. Absent HexA, progressive neurodegenerative symptoms of TSD emerge in infancy, typically leading to death by age 4. Though rare, this fatal disorder has no available treatment. Current Status: Recent advances in CRISPR gene editing technology have excited prospects of genetically treating TSD by directly editing out the duplication. A CRISPR-based technique called Prime Editing can repair various kinds of mutations, including the TSD duplication in a cell model, but its molecular components are too large for effective delivery to live animal models.Research Aim:Forgoing the versatility of Prime Editing, an alternative strategy tailored for editing small duplication mutations can circumvent bulky editing machinery by exploiting an internal cell pathway called MMEJ to effectuate repair. A classic CRISPR system (readily deliverable components) would be programmed to cut within the duplicated sequence at a position that induces the MMEJ repair process. Mechanistically, MMEJ is expected to rejoin the DNA break while collaterally, but precisely, removing one copy of the duplication. Our capstone deliverable is testing this minimalist CRISPR-based repair strategy on the TSD duplication in a mouse model, with precision of the DNA-level editing examined alongside efficacy of TSD symptom amelioration for relevant pre-clinical data. If successful, this strategy would be highly applicable to editing over 140 comparable duplication mutations causing various diseases.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hung, Joshua E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~